It’s that time of the year again. I’m not referring to buying gifts and preparing holidays meals— all though that may be part of your agenda too. It’s time to look back on your portfolio’s performance and plan for the year ahead.
it’s been a solid year for many with all three indexes heading for triple-digit gains, and with the right mix of stocks we might make 2025 a winning one too. Most importantly though, remember to focus on the long term, as gains over a number of years are what we are really looking for–so don’t worry if your portfolio hasn’t perform as well as you’d hoped during any particular year, including this one.
Need some more inspiration for stocks to buy right now? Here are my top 10 buys — in on particular order — for 2025 and beyond. Most of these stocks have a solid earning track record (expect for the clinical-stage Biotech that hasn’t yet generated products revenue). And they all have bright long term prospect.
1. Nvidia
Even though Nvidia (NASDAQ:NVDA) has soared more 160% this year I still think this player has room to run. A key catalyst is unfolding right now: This top artificial intelligence (AI) cheap designer is ramping production on its Blackwell architecture, and demand is “staggering” the company has said.
Blackwell is expected to add billions of Dollar to revenue in its first quarter up commercialisation, with gross margin of more than 70% Nvidia’s commitment to innovation should keep it ahead of Rivals, making the stocks looked reasonable price today at 43x forward earning estimates.
2. Pfizer
Pfizer (NYSE:PEE) shares have struggle as the companies blockbuster called a virus production saw steep decline in demand. But Pfizer has shifted focus to a huge badge of new products with the launch of 19 in a period of 18 months and it growing on oncology business.
last year Pfizer acquired seagen to strengthen it’s oncology presence, and its set big goals the company aims to launch 8 or more blockbuster on oncology medicines by 2030, and its wants to double the number of patients taking its on oncology drugs.
This represents a potential new wave of growth ahead,making now a great time to get in on the stock.
3. Viking Therapeutics
Viking Therapeutics (NASDAQ:VKTX) Is working in the hot growth area of obesity treatments. The company hasn’t yet commercialized a product but its about to enter face 3 trial with VK2735. This candidate belong to the same class of drugs as blockbuster zepbound made by Eli Lilly, but demand is so strong in the market that there’s room for several players.
The company has catalysts in the form of clinical trial data reports that could offer the stock direction in the coming year. After a positive report earlier this year the shares soared about 120% in one trading session. This may not be the case every time,but if VK2735 continues to deliver in encouraging results, Viking could climb in 2025.
4.Amazon
Amazon (NASDAQ:AMZN) is an early winner in the AI space. The company uses AI to make its E-Commerce operations more efficient, and it sales AI products and services through Amazon Web service (AWS).
And the reason to buy Amazon now? It’s AI investment is starting to bear fruit. On the e-commerce side, Amazon is lowering cost to serve as it improves operations across the full fillment network — for example,bringing inventory closer to customers. And revenue at AWS is taking of thanks to Ai demand. In recent quarter AWS reported a 110 billion US dollar annualized revenue run rate.
Amazon already is a leader in E-commerce and cloud computing and its heading for dominance in AI too.
5. Etsy
Etsy (NASDAQ:ETSY) sales mainly discretionary items so it’s struggled during Times Of Higher inflations, as consumers had Limited buying power. But it could make a big come back as shopper start spending more in a stronger economy.
What I really like about Etsy is its capital-light business model. Etsy provides an online platform for artisans to sell their wares and for us to buy them. But Etsy doesn’t take care of the stocking and transport of items, keeping its capital investments low. This allows Etsy to turn most of its adjusted earning before interest, Texas, depreciation and amortization (EBITDA) into free cash flow 90% in the recent quarter.
The stock traders for only 13x forward earnings estimates, so it could be a great time to stock up on its.